Takeda Pharmaceutical Company Ltd is the largest Asian pharmaceutical corporation which has been established in 1781 in Japan. It is one of the biggest companies in the world which took 10 position in 2014 according to the sales volume.
Takeda is available at all developed and developing markets and offers a broad spectrum of the pharmacological production: prescription drugs, over-the-counter drugs, medical equipment, and others.
As the largest pharmaceutical company in Japan and one of the world leaders of the industry, Takeda tries to improve the health of the patients all over the world by means of the implementation of the leading innovations in the field of the medicine.
The base of the product portfolio of the company consists of brand prescription drugs which are used in gastroenterology, cardiology, neurology, analgesia, prevention of osteoporosis, surgery, and treatment of respiratory and inflammatory diseases.
A wide range of the over-the-counter drugs fulfills the portfolio.
The main medical drugs which are developed and released by Takeda company or mutually with partners are: Actos, Amitiza, Blopress, Kapidex, Lupron, Prevacid, Prevpac, Velcade, Brintellix, Edarbyclor, Rozerem, Xefocam, Atenolol, Glucophage, Ninlaro, Cardiomagnyl, Euthyrox, and others.
Takeda actively works over the expansion of its affiliate companies, and therefore different deals are performed on merging this corporation with other pharmaceutical companies every year.
Due to the separate structure of The Takeda Oncology Company under the supervision of the head office, Takeda Pharmaceutical Company Ltd conducts an active research work in the section of oncology, and achieves very significant results. In 2012, this structure of the company entered top 100 best companies in the USA which work under the oncologic diseases and develop drugs for the treatment of these pathologies.